Data as of 9:30am ET
| +0.26 / +4.91%|
The 1 analysts offering 12-month price forecasts for SkyePharma PLC have a median target of 7.51, with a high estimate of 7.51 and a low estimate of 7.51. The median estimate represents a +35.10% increase from the last price of 5.56.
The current consensus among 1 polled investment analysts is to Buy stock in SkyePharma PLC. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.